Skip to content

Gastric mucosa secretion of FD with weight loss and the influence of antidepressant mirtazapine

Gastric mucosa secretion of FD with weight loss and the influence of antidepressant mirtazapine

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007460
Enrollment
Unknown
Registered
2015-11-25
Start date
2015-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia

Interventions

contrast group:Taking routine medicine, such as PPI and gastric mucosa
mirtazapine group:Taking mirtazapine and routine medicine
Paroxetine group:Taking Paroxetine and routine medicine

Sponsors

Guangzhou First Municipal People's Hospital, Guangzhou Nan Sha Center Hospital Affiliated to Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnose criterion of FD Roman III(symptoms lasting at least sis months,and in later three months symptoms include plump,early full feeling,epigastric pain and epigastric burning; 2. The criterion of depressive disorder is according to the CCMD-3,and the grade of HAMD is at least 18; 3. Aged between 18 and 65 years old; 4. Signature the informed consent.

Exclusion criteria

Exclusion criteria: 1. Organic diseases such as ulceration, erosion,tumor and oesophagitis are checked by endoscopy; 2. Lab,B ultrasonic and X-ray discover disease of liver, gallbladder, pancreat and colon; 3. Loss weight and gastric symptoms is caused by diabetes, hyperthyroidism and tuberculosis; 4. Anorexia patients; 5. Being in pregnancy and lactation.Disability; 6. Being taking other similar drugs or taking drugs of the same kind in 15 days; 7. Being in severe anxiety-depression; 8. Being taking NSAID, hormone and drugs influencing gastric acid.

Design outcomes

Primary

MeasureTime frame
Pepsinogen;Gastrin-17;cholecystokinin;

Countries

China

Contacts

Public ContactLin Jia
13925012851@139.com+86 13925012853

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026